Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) Rabbit Monoclonal Antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0446833
- Awardee
- CELL SIGNALING TECHNOLOGY INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $401.40
About this award
The University of Virginia awarded contract A207_PO-0446833 to Cell Signaling Technology Inc. on June 9, 2026, for the procurement of specialized laboratory reagents. The contract involves the delivery of one Phospho-p38 Mitogen-Activated Protein Kinase (Thr180/Tyr182) (D3F9) Rabbit Monoclonal Antibody to Keena Seagle Thomas. The total contract value is $401.40, with a unit price of $401.40 per item.
This purchase order represents a straightforward procurement of a single research-grade antibody product for use at the University of Virginia in Virginia. Cell Signaling Technology Inc. served as the prime contractor for this award. The contract was executed in June 2026, and no additional contract performance period details beyond the award date are specified in the available documentation.
Line items
| Item | Total |
|---|---|
| Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) Rabbit Monoclonal Antibody | $401.40 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0446833?
Contract A207_PO-0446833 was awarded to CELL SIGNALING TECHNOLOGY INC. by University of Virginia on June 9, 2026.
How much is contract A207_PO-0446833 worth?
Its cumulative value is $401.40.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award